Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Indian J Biochem Biophys ; 51(3): 207-10, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25204082

RESUMEN

The activating mutations of the Ras gene or other abnormalities in Ras signaling pathway lead to uncontrolled growth factor-independent proliferation of hematopoietic progenitors. Oncogenic mutations in NRAS gene have been observed with variable prevalence in hematopoietic malignancies. In the present study, NRAS mutations were detected using bidirectional sequencing in 264 acute leukemia cases--129 acute lymphocytic leukemia (ALL) and 135 acute myeloid leukemia (AML) and 245 age- and gender-matched controls. Missense mutation was observed only in the 12th codon of NRAS gene in 4.7% of AML and 3.16% of ALL cases. The presence of NRAS mutation did not significantly influence blast % and lactate dehydrogenase (LDH) levels in AML patients. When the data were analyzed with respect to clinical variables, the total leukocyte count was elevated for mutation positive group, compared to negative group. In AML patients with NRAS mutations, 60% failed to achieve complete remission (CR), as compared to 34.8% in mutation negative group. These results indicated that NRAS mutations might confer poor drug response. In AML, disease free survival (DFS) in NRAS mutation positive group was lesser, compared to mutation negative group (9.5 months vs. 11.68 months). In ALL patients, DFS of NRAS mutation positive group was lesser than mutation negative group (9.2 months vs. 27.5 months). The CR rate was also lower for mutation-positive patients group, compared to mutation-negative group. In conclusion, these results suggested that presence of NRAS mutation at 12th codon was associated with poor response and poorer DFS in both ALL and AML.


Asunto(s)
GTP Fosfohidrolasas/genética , Leucemia Mieloide Aguda/genética , Proteínas de la Membrana/genética , Mutación/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Leucemia Mieloide Aguda/epidemiología , Leucemia Mieloide Aguda/mortalidad , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/epidemiología , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidad , Prevalencia , Pronóstico , Tasa de Supervivencia
2.
J Ethnopharmacol ; 337(Pt 2): 118855, 2024 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-39332616

RESUMEN

The study evaluated 297 carrot germplasm lines, focusing on 52 cultivars to explore their therapeutic potential and address challenges related to the accessibility and affordability of nutraceuticals and health promoting foods. The investigation explores the application of DNA barcoding using the ITS region for precise species identification, highlighting genetic diversity among the examined cultivars. Through ITS sequence-based analysis and phylogenetic examination, six diverse Daucus spp. genotypes were differentiated and classified into distinct groups, indicating the presence of vast genetic variation. Evaluation of antioxidant activities using the DPPH radical scavenging assay revealed varying degrees of scavenging ability among genotypes with SKAU-C-15, SKAU-C-17, and SKAU-C-16 exhibiting the highest activity, suggesting their potential for antioxidant-rich products. Thin Layer Chromatography (TLC) bioautography confirmed the presence of bioactive compounds in carrot extracts responsible for their antioxidant properties. In cell culture studies, specific carrot genotype extracts demonstrated potential anti-proliferative and anti-invasive effects on recurrent prostate cancer cell line - C4-2 (SKAU-C-30, SKAU-C-10, and SKAU-C-42) and non-small cell lung cancer cell line - A549 (SKAU-C-18 and SKAU-C-11) cancer cells, as indicated by MTT assay, wound healing assay, and Colony Forming Unit assay. These findings suggest the promising therapeutic potential of carrot genotypes for developing anti-cancer functional foods, nutraceuticals and health supplements.Therefore, the study contributes to the nutrition security, paving the way for advancements in functional foods and health applications, particularly in cancer treatment and prevention.

3.
Environ Sci Pollut Res Int ; 30(8): 21900-21913, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36279066

RESUMEN

This paper analyzes the economics of a grid-interactive rooftop solar photovoltaic (PV) system and the impact of the temperature on it. The analysis related to energy metrics, lifecycle costing, and environmental economics was performed considering the PV system's life as 30 years. The system economics is also compared at different conditions like theoretical, temperature-corrected, and real electricity generation data. The parameters like energy payback time (EPBT), energy return on energy invested (EROI), and lifecycle conversion efficiency are determined as 5.95 years, 5.04, and 0.078, respectively, based on actual generation. The unit electricity cost of the rooftop PV system was estimated as INR 5.37 at the 5% interest rate. The electricity cost varies with the interest rate variation and operation system life. The results show a reduction in overall economic performance on the increase in module temperature. The effect of temperature on the economics of the system is presented in terms of the per degree rise of module temperature. One degree increase of module temperature 8.5 days in EPBT of the PV system increases, and INR 0.021 increases in the unit cost of electricity considering a reference temperature 25 °C. A PV system has environmental benefits by reducing greenhouse gas emissions, which are also affected by the rise of module temperature. The system lost INR 355.93 in carbon credits at an increase of one-degree module temperature.


Asunto(s)
Energía Solar , Temperatura , Electricidad , Carbono
4.
Heliyon ; 8(7): e09941, 2022 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-35874084

RESUMEN

With lead-based light harvesters, perovskite solar cells (PSCs) have an efficiency of approximately 25.5%, making them a viable photovoltaic technology. The selection of the absorber materials for PSC in this work are (i) Cesium lead iodide (CsPbI3) with a 1.73eV bandgap as the first absorber layer, this halide imparts higher stability to perovskite solar cells (ii) CH3NH3PbI3 (MAPbI3) with a bandgap of 1.55eV is selected as the second absorber layer as this material provides better efficiency to the perovskite solar cells. SCAPS-1D simulation software is used to perform an efficiency analysis of perovskite-perovskite CsPbI3/MAPbI3 bilayer solar cell. For efficiency optimization of the perovskite-perovskite bilayer solar cell, we have tried to calibrate seven parameters of the cell. These parameters are (i & ii) selection of the electron and hole transport material (iii, iv & v) variation in the: defect density of bulk material, doping concentration and the thickness of absorber layers, (vi) variation in work function of front electrode (vii) varying interface defect density. After optimization, the efficiency (η) of bilayer PSC is estimated to be 33.54%. The other PV parameters observed in optimal efficiency condition are open-circuit voltage (VOC) = 1.34V, short-circuit current density (JSC) = 27.45 mA/cm2 and fill factor (FF) = 90.49%. The CsPbI3/MAPbI3 bilayer perovskite solar cell efficiency is roughly double the efficiency of single junction CsPbI3 or MAPbI3 PSC. Our analysis observed that the variation in the doping and defect density of narrow bandgap material profoundly impacts the efficiency of perovskite-perovskite bilayer solar cells compared to the wide bandgap material.

5.
Asian Pac J Cancer Prev ; 11(6): 1811-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21338238

RESUMEN

Mutations in FLT3 and NPM1 are important prognostic factors in AML, influencing outcome in normal karyotype cases. We here analysed incidences of FLT3/ITD, D 835 and NPM1 mutations in patients with de novo normal karyotype AML using PCR and gene sequencing, along with laboratory parameters and treatment outcomes. There were 128 patients with a median age of 45 years (range, 19-65). FLT3/ITD mutations were detected in 26 (20.3%), FLT3/D835 in 8 (6.2%) and NPM1 in 22 (17.1%). The incidence of FLT3/ITD was higher in those with elevated lactate dehydrogenase (LDH) and peripheral blasts (p=< 0.002, < 0.001) while NPM1 mutations or both NPM1 and FLT3/ITD was more common in elevated total leukocyte counts (TLC), LDH and peripheral blasts (p=<0.0001). Complete response and disease free survival were lower in those with FLT3/ITD mutations (p=0.04, 0.03). The incidence of FLT3 and NPM1 mutations was found to be low in Indian patients with normal karyotype AML.


Asunto(s)
Leucemia Mieloide Aguda/genética , Mutación/genética , Proteínas Nucleares/genética , Tirosina Quinasa 3 Similar a fms/genética , Adulto , Anciano , Secuencia de Bases , ADN de Neoplasias/genética , Femenino , Estudios de Seguimiento , Humanos , Cariotipificación , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Nucleofosmina , Reacción en Cadena de la Polimerasa , Pronóstico , Estudios Prospectivos , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento , Adulto Joven
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda